Introduction: Smokers are using electronic cigarettes, also known as e-cigarettes, as a cessation aid, despite uncertainty about their efficacy. This report describes the association between use of e-cigarettes before and after cessation treatment and tobacco abstinence at 12 months. It also presents characteristics of e-cigarette users and reasons for use. Methods: A longitudinal observational secondary analysis of self-reported e-cigarette use was conducted among adult Appalachian smokers enrolled in a community-based tobacco dependence treatment trial (n = 217). Data were collected at baseline, 3, 6, and 12 months following treatment. The primary outcome measure was biochemically-confirmed 7-day point prevalence tobacco abstinence at 12 months post-treatment. Results: One in five participants reported using e-cigarettes post-treatment. Baseline sociodemographic and tobacco-related characteristics did not differ by e-cigarette use. Primary reasons for e-cigarette use included help in quitting, help in cutting down on cigarettes, and not as bad for health. At the 12 month follow-up, tobacco abstinence was significantly lower among posttreatment e-cigarette users (4.7%) than nonusers (19.0%); (OR = 0.21 95% CI: 0.05-0.91, p = .021). Baseline use was not associated with 12-month abstinence. Conclusions: Among adult Appalachian smokers enrolled in community-based tobacco cessation treatment, use of e-cigarettes post-treatment was associated with lower abstinence rates at 12 months. Implications: This descriptive report of electronic cigarette use after participation in a communitybased group randomized tobacco dependence treatment trial adds to the body of science examining e-cigarette use and cessation. Post-treatment e-cigarette use was associated with less success in achieving abstinence at 12 months, as compared to nonuse. At 3 months post-treatment, the majority of those who reported use of e-cigarettes did so to assist with cessation.
Introduction
The majority of US adult smokers want to quit 1 and many are turning to electronic cigarettes, known as e-cigarettes, as an alternative to smoking. Reasons for e-cigarette use include assistance to reduce or quit smoking, reduced health risks, and maintenance of smoking where cigarettes are restricted. [2] [3] [4] [5] One in five current smokers report e-cigarette use some days; 3.7% use daily. 2 Among smokers, ever e-cigarette users are more likely to be white 3, 6 and young adults. 4, 6 Compared to nonusers, e-cigarette users have a higher motivation to quit and a higher quitting self-efficacy, 7 use more quit methods (ie, nicotine replacement therapy [NRT] ), are more nicotine dependent, 8 and have attempted to quit in the past year. 3 Two clinical trials have examined the efficacy of e-cigarettes as a cessation aid. Bullen et al. 9 found that e-cigarettes are modestly effective at helping smokers quit, and Caponnetto et al. 10 demonstrated that among smokers not intending to quit, e-cigarette use decreased cigarette consumption. A cross-sectional study in the UK 11 found that e-cigarette users were more likely to report abstinence than those who used over-the-counter NRT or no aid. A systematic review concluded that e-cigarettes could alleviate smoking withdrawal symptoms and cravings in laboratory settings. 12 Moreover, a decision-theoretic model found that vaporized nicotine products could have a positive public health impact. 13 However, others have commented and questioned the assumptions and specific approaches underlying this analytic model. 14, 15 In contrast, a random effects meta-analysis of twenty studies with control groups found the odds of quitting cigarettes were 28% lower in e-cigarette users compared with non e-cigarette users. 16 In two recent longitudinal studies, 17, 18 e-cigarette users were less likely to be abstinent at follow-up, although findings from the Swiss study were not statistically significant. Only a few studies have investigated e-cigarette use in smokers trying to quit. Among quit-line callers 3 and cancer patients enrolled in a cessation study, 19 e-cigarette users had a significantly lower abstinence at follow-up than nonusers. Recently, Zawertailo and others observed lower abstinence among primary care clinic patients who used e-cigarettes while attempting to quit smoking. 20 Very few studies have described e-cigarette use as a cessation aid in trials that involved local community-based agencies. 21 In this paper, we report e-cigarette use among Ohio Appalachian adults who wanted to quit smoking and were enrolled in a communitywide treatment trial. The purposes of this secondary analysis were to describe: (1) sociodemographic and tobacco-related characteristics associated with e-cigarette use post-treatment, (2) reasons for e-cigarette use at 3, 6, and 12 months, and (3) the association between e-cigarette use pre-and post-treatment and biochemically confirmed 7-day point prevalence tobacco abstinence at 12 months.
Methods

Study Overview
A secondary analysis was conducted using data from a 10-week group randomized cessation treatment trial that included participants from 12 Ohio Appalachian counties. 21 Six counties each were randomly assigned to one of two treatment conditions: faceto-face counseling or referral to the Ohio Tobacco Quitline. Both treatment conditions included standardized cognitive-behavioral counseling and free NRT (daily 21 mg patch for 8 weeks) as recommended by the US Public Health Service "Treating Tobacco Use and Dependence" guideline. 22 Baseline and post-treatment (ie, 3, 6, and 12 months follow-up) data were collected. The study was approved by the university's Institutional Review Board.
Procedure
Recruitment occurred at geographically and socioeconomically distributed community sites within each county. Eligibility criteria included: (1) age 18 or older; (2) self-reported daily use of combustible tobacco; (3) resident of a participating county; (4) no contraindication to NRT; (5) if female, non-pregnant; (6) willing to participate in study protocol; and (7) provision of written informed consent.
Sample
Data collection started in November 2010, with items to assess e-cigarette use added to surveys in April 2012 due to their increased marketing in the United States. As there was no statistically significant difference in 12-month abstinence by treatment condition (p = .29) and use of e-cigarettes was similar between treatment conditions (p = .49), data were combined for this secondary analysis. We report on the subset of the total sample enrolled from April 2012 to October 2013 who provided complete answers to use of other tobacco products at baseline, 3, 6, and 12 months (n = 217).
Measures
Baseline Sociodemographic (age, gender, race, education, poverty level, selfrated health, and health insurance status) and tobacco-related characteristics were collected in the baseline questionnaire. Variables included baseline e-cigarette use, years smoked, age of initiation, number of cigarettes smoked per day, Fagerström Test for Nicotine Dependence (FTND), 23 number of previous quit attempts, use of quitting resources in the past, Decisional Balance Scale for Smoking, 24 confidence to quit, Quitting Self-Efficacy Score, 25 indoor home cigarette smoking rules 26 (allowed anywhere inside the home, allowed in some places or at sometimes, not allowed anywhere inside the home) and whether a worksite smoking policy existed.
Post-Treatment
The main exposure variable of interest was e-cigarette use posttreatment. At 3, 6 and 12 month follow-ups, participants were asked if they used any kind of tobacco in the past 7 days. Those answering yes were asked if they currently use e-cigarettes every day, some days, or not at all. The variable, "e-cigarette use post-treatment" was defined as self-reported past 7-day e-cigarette use (every day or some days) at 3, 6, and/or 12 months. Due to the small sample size, every day and some day use were combined.
The primary outcome measure was 7-day point prevalence abstinence from tobacco (not including e-cigarettes) at 12 months posttreatment, defined as self-report of no tobacco use in the past 7 days as confirmed by a saliva cotinine concentration of <15 ng/mL, or by expired air carbon monoxide level of < 8 parts per million if participant was using NRT or e-cigarettes. 27 Those reporting e-cigarette use were asked reasons for use at every time point (3, 6 , and 12 months). Six response categories included: (1) they may not be as bad for your health; (2) they taste better; (3) they make it easier to cut down on the number of cigarettes you smoke; (4) so you can smoke in places where smoking regular cigarettes is banned; (5) they may help you quit; and, (6) they are cheaper.
In addition to baseline characteristics, other potential confounders included total number of in-person counseling visits and number of patches used (face-to-face treatment condition) and number of calls to the quit-line and number of weeks of patches received (quitline treatment condition).
Statistical Analysis
Data were analyzed in STATA. Sociodemographic and tobaccorelated characteristics were compared between those who used e-cigarettes post-treatment and those who never used e-cigarettes post-treatment. Means and t tests were used for continuous variables and percentages, chi-square tests and Fisher's exact tests were used for categorical variables. No correction was made for multiple comparisons, but the p-values are provided for descriptive purposes.
For the primary analysis, a Fisher's exact test assessed the association between use of e-cigarettes post-treatment and 12-month point prevalence tobacco abstinence. A mixed effects logistic regression analysis was also performed to assess this association as well as the impact of potential confounders and the impact of within county correlation. These models indicated that the within county correlation on the outcome was zero, so the presented analyses utilize methods for independent data. Due to the small sample size, statistical modeling that examined time-dependent issues was not performed.
Results
Among the 217 participants who provided complete data, 19.8% reported e-cigarette use post-treatment. The percentage of e-cigarette users generally increased over time: 7.8% at 3 and 6 months and 12.0% at 12 months.
Characteristics of E-Cigarette Users
The majority of e-cigarette users were 25-54 years old (53.5%), female (76.7%), white (97.6%), had more than a high school degree or GED (58.1%). Approximately 13% lived below the 100% federal poverty level and 23% did not have health insurance. These characteristics were similar to the characteristics of nonusers (Table 1) and the sample as a whole. 21 Some difference was found in self-rated health with 51% of e-cigarette users reporting fair or poor health, as compared to 30% among never users (p = .020).
Smoking history variables did not differ significantly by e-cigarette use post-treatment (Table 1) . On average, e-cigarette users smoked cigarettes for 31 years, started smoking around age 17, smoked 22 cigarettes/day, and had moderate nicotine dependence, based on FTND scores. E-cigarette user FTND scores resembled nonuser scores.
There were no associations between baseline quitting history variables and e-cigarette use. In the past 12 months, on average, e-cigarette users attempted to quit one time for at least 24 hours. Approximately three-quarters of e-cigarette users had previously used resources to aid in quitting (NRT, other medication, quit-lines, community or internet programs, self-help materials, and/or healthcare providers). E-cigarette users on average scored 7 in their confidence to quit smoking (1 = not at all confident, 10 = extremely confident).
While 56% of e-cigarette users were allowed to smoke anywhere inside the home, only 39% of nonusers had this same rule (p = .068). Fewer e-cigarette users had a smoking policy at work (67% vs. 85%, p = .10). These differences were not significant.
Reasons for E-cigarette Use
At every follow-up, the top three reasons for e-cigarette use were: (1) help in quitting; (2) help in cutting down on cigarettes; and (3) not as bad for health. Reported reasons for use diminished over time. While 53% of e-cigarette users reported that they help in cutting down on the number of cigarettes you smoke at 3 months, only 18% and 15% reported this reason at 6 and 12 months, respectively.
E-cigarette Use and Tobacco Cessation
Four times as many participants who reported no use of e-cigarettes post-treatment were tobacco abstinent at 12 months, as compared to those who used post-treatment (19.0% vs. 4.7%, p = .021). This difference corresponded to an odds ratio of 0.21 comparing those who used post-treatment to those who did not use post treatment (95% CI: 0.048, 0.906). Secondary analyses further stratified groups based on baseline e-cigarette use. Those who used e-cigarettes at baseline but did not use post-treatment had an abstinence rate of 16.7% while never-users at both baseline and post-treatment had an abstinence estimate of 19.3% at 12 months. Conversely, baseline users who also used e-cigarettes post-treatment had an abstinence rate of 6.7%, while 3.6% of post-treatment only e-cigarette users were abstinent at 12 months. As compared to baseline and posttreatment never users (referent), participants who reported baseline use but no post-treatment use had lower odds of 12-month abstinence (OR = 0.834; 95% CI 0.265, 2.629). Those who reported use at baseline and post-treatment, as well those who used e-cigarettes at post-treatment only, had lower odds of 12-month abstinence compared to never e-cigarette users (OR = 0.298; 95% CI 0.038, 2.359 and OR = 0.155; 95% CI 0.020, 1.184, respectively) ( Table 2) .
Number of counseling visits and adherence to nicotine patches (face-to-face treatment condition), and number of calls to the quitline and weeks of patches received (quit-line treatment condition), did not confound the association (data not shown). Additionally there was no relationship between 12-month abstinence and "every day" versus "some day" e-cigarette use (data not shown).
Discussion
Among adult Appalachian smokers enrolled in a community-based tobacco cessation trial, post-treatment e-cigarette use was associated with less success in achieving abstinence at 12 months, as compared to nonuse. This finding adds to the growing number of observational studies 3, 8, [16] [17] [18] [19] [20] that have examined e-cigarette use and cessation. These results are similar to findings among participants enrolled in other smoking cessation studies, 3, 19, 20 which reported lower abstinence among e-cigarette users. Interestingly, e-cigarette users reported many reasons for use at 3 months; at 6 and 12 months fewer participants reported each reason. Potentially, over time the intent of quitting is replaced with the routine use of an additional product.
It is also possible that failed quitters turned to e-cigarettes. Past studies have been criticized 28, 29 for excluding people who used e-cigarettes and then successfully stopped smoking. This study described e-cigarette use and abstinence among participants who intended to quit smoking upon enrollment and took baseline and post-treatment use into account. Additionally, while past studies have identified past quitting history as a potential confounder in the association between e-cigarette use and tobacco cessation, 3, 8, 18 our study does not support this idea. A major limitation of this analysis was its observational design, which limits any causal inferences about e-cigarette use post-treatment for tobacco cessation. Moreover, the small sample size limited the power of the study and ability to use more complex statistics and parse out time-dependent issues. The follow-up question used to identify e-cigarette users at 3, 6, and 12 months post-treatment only screened for e-cigarette use in the past 7 days and thus potential e-cigarette users were likely missed. Additionally, this study does not differentiate between type of e-cigarette device or the amount of nicotine in the device. Newer types of e-cigarettes may be more effective. 29 Finally, this is a homogenous study population representing those trying to quit and residing in Appalachian Ohio, a region characterized by a high prevalence to tobacco use and burden of disease. In conclusion, this study adds to our limited understanding of e-cigarette use among community residents that are seriously trying to quit smoking. Post-treatment e-cigarette use was associated with less success in achieving abstinence at 12 months, as compared to nonuse.
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